Source: Health Canada shortage reports · Updated Oct 2, 2026
Some Minocycline products are in shortage in Canada (1 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 13, 2026.
A tetracycline antibiotic used to treat bacterial infections and acne.
Products affected
1 / 10
In shortage since
Sep 29, 2026
Est. full return
Nov 13, 2026
Reports on file
33
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
MINOCYCLINE
100MG · CAPSULE · AA PHARMA INC
DIN 02084104 · since Sep 29, 2026, est. end Nov 13, 2026 · Disruption of the manufacture of the drug.
Resolved
MINOCYCLINE
50MG · CAPSULE · AA PHARMA INC
DIN 02084090 · ended Jan 6, 2025 · Disruption of the manufacture of the drug.
Resolved
MINOCYCLINE
100MG · CAPSULE · AA PHARMA INC
DIN 02084104 · ended Nov 19, 2024 · Disruption of the manufacture of the drug.
Avoided
MINOCYCLINE
100MG · CAPSULE · AA PHARMA INC
DIN 02084104 · ended Jun 10, 2021 · Disruption of the manufacture of the drug.
Avoided
MINOCYCLINE
50MG · CAPSULE · AA PHARMA INC
DIN 02084090 · ended Jun 10, 2021 · Disruption of the manufacture of the drug.
Discontinued
PMS-MINOCYCLINE
100MG · CAPSULE · PHARMASCIENCE INC
DIN 02294427
Resolved
PMS-MINOCYCLINE
100MG · CAPSULE · PHARMASCIENCE INC
DIN 02294427 · ended Jun 5, 2020 · Product in discontinuation process
Product already discontinued DIN cancelled post market.
Discontinued
MYLAN-MINOCYCLINE
50MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02230735
Discontinued
MYLAN-MINOCYCLINE
100MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02230736
Resolved
MYLAN-MINOCYCLINE
100MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02230736 · ended Sep 17, 2019 · Disruption of the manufacture of the drug.
Resolved
MYLAN-MINOCYCLINE
50MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02230735 · ended Sep 17, 2019 · Disruption of the manufacture of the drug.
Resolved
MYLAN-MINOCYCLINE
100MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02230736 · ended Sep 17, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 33 reports. All reports are on file with Health Canada.
What's happening
Minocycline is currently affected by an active shortage report filed with Health Canada by AA PHARMA INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Minocycline is classified under “TETRACYCLINES” (ATC J01AA).
Recent changes
Oct 2, 2026
New report filed
Common questions
What is Minocycline used for?
A tetracycline antibiotic used to treat bacterial infections and acne.
When will Minocycline be back in stock in Canada?
The latest manufacturer estimate is Nov 13, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Minocycline in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (tetracyclines)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.